In a phase I study of the immunocytokine NHS‐IL12 in patients with metastatic solid tumours, TIL density and diversity were increased in tumour lesions of patients with a more robust IFN‐γ response; importantly, T‐cell clones expanded within the tumour were also detected in paired peripheral blood, and vice versa.17 This evidence concerns the gene IFNG and neoplasm.